Wei-Hsin Chiu

Wei-Hsin Chiu

Auto-generated profile, based on publicly available information

Wei-Hsin Chiu

Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Biochemical Pharmacology
Verified
Journal Article
Closed access
WCWei-Hsin Chiu
Wei-Hsin Chiu
SLSheng-Jei Luo
Sheng-Jei Luo
CCChia-Ling Chen
Chia-Ling Chen
Jai-Hong ChengJai-Hong Cheng
Jai-Hong Cheng
CHChia-Yuan Hsieh
Chia-Yuan Hsieh
CLChiou-Feng Lin
Chiou-Feng Lin

1 June 2021 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
WLWei-Shu Lai
Wei-Shu Lai
WLWen-Wen Li
Wen-Wen Li
WCWei-Hsin Chiu
Wei-Hsin Chiu

12 September 2018 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YWYan-Wei Wu
Yan-Wei Wu
CLChiou-Feng Lin
Chiou-Feng Lin
YLYee-Shin Lin
Yee-Shin Lin
WSWu-Chou Su
Wu-Chou Su
WCWei-Hsin Chiu
Wei-Hsin Chiu
Autophagy is one of the induced mechanisms in metastatic cancer to escape death due to starvation, hypoxia, metabolic stresses, chemotherapy, and radiation. Some publications have revealed that chemotherapy combined with autophagy inhibitor will overcome drug resistance. We modified AS2 cells with PTEN overexpression, mTOR knockdown, or Keap1 knockdown, and made modification of A549 cells with PTEN knockdown, Atg5 knockdown, and Keap1 overexpression. Our study was aimed toward an exploration of how autophagy modulates Keap1, ROS generation, and vinorelbine-induced apoptosis in these cell lines. We found that lung cancer PC14PE6/AS2 (AS2) had higher mTOR and Akt and also lower PTEN expression than A549 cells. Descended autophagy was demonstrated with more decreased p62 accumulation and LC3 II conversion in AS2 cells as compared to A549 cells. The A549 cells had lower Keap1/Nrf2 and more active anti-oxidant response element (ARE) activity than the AS2 cells. We modified AS2 cells with PTEN overexpression, mTOR knockdown, Keap1 knockdown, and revealed amplified p62 and LC3 expression accompanied with decreased Akt, Keap1, ROS, and vinorelbine-induced apoptosis. Declined p62, LC3 expression were accompanied with increased Akt, Keap1, ROS, and vinorelbine-induced apoptosis after modification of A549 cells with PTEN knockdown, Atg5 knockdown, and Keap1 overexpression. Keap1 overexpression lowered ARE levels in A549 cells, and ARE level exhibited up-growth in Keap1 knockdown AS2 cells. The autophagy inhibitor caused more ROS generation and vinorelbine-induced apoptosis in the A549 and CL1-5 cells. According to these findings, autophagy regulates vinorelbine sensitivity by continuing Keap1-mediated ROS generation in lung adenocarcinoma cells.

1 September 2018 in Holistic Nursing Practice
Verified
Journal Article
Closed access
YSYa-Lan Shih
Ya-Lan Shih
YHYu-Ching Hsu
Yu-Ching Hsu
WCWei-Hsin Chiu
Wei-Hsin Chiu
CCCo-Shi Chantal Chao
Co-Shi Chantal Chao
Preparing for a good death is an important and meaningful concept in Chinese culture because people hope to know residual life to make effort for their unfinished business. However, the family of terminally ill patients with cancer may be annoyed and frustrated about unexpected bereavement if they have unresolved conflicts with the loved one, missing a chance for declaring love, untimely apologizing and saying goodbye. The study aimed to explore this difficult issue. The medical records of 121 deceased terminally ill patients with cancer at National Cheng Kung University Hospital between December 2010 and February 2012 were reviewed. The signs and awareness of dying among these patients were collected using palliative routine instruments in the hospice ward. The top 3 most prevalent dying signs were coolness and cyanosis (prevalence 98.3%, median period from the first documented dying sign to death 2 days, P = .028), mirror-like tongue (prevalence 94.2%, median period 5 days, P = .007), and earlobe crease (prevalence 93.4%, median period 4 days, P = .052). In addition, the prevalence of dying awareness was 71.1% (median period 4 days, P = .001). Furthermore, terminal agitation was identified more frequently in terminally ill patients with hepatoma and colon cancer (adjusted odds ratio = 3.240, P = .043), but turbid sclera with edema was noted more often in terminally ill patients with head and neck cancer (adjusted odds ratio = 5.698, P = .042). The results provide evidence to support clinical practice, offering knowledge and techniques to health care providers, and increasing quality of life for terminally ill patients with cancer.